Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

    Recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark France +7
  • Adalimumab, Doxycycline, and Resorcinol for Adults with Early Hidradenitis Suppurativa at High Risk of Progression to Severe Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Greece +6
  • A study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands Poland
  • Study to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Spain
  • Study on Fecal Microbiota Transplantation and Amoxicillin-Clavulanic Acid for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on the Use of Adipose-Derived Stem Cells for Treating Hidradenitis Suppurativa in Patients with Draining Fistulas

    Not yet recruiting

    1 1
    Spain
  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Greece Poland Spain
  • Study of Tibulizumab to Treat Adults with Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Hungary Poland Spain
  • Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Hungary +7